Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Cancer treatments Stories

2012-12-10 08:25:43

REDWOOD CITY, Calif., Dec. 10, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the results from six studies of the Oncotype® DX breast cancer test presented at the 34(th) Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) reinforcing the impact of the test on facilitating better informed treatment decisions in patients with node-negative and node-positive invasive early-stage breast cancer. Additionally, two studies demonstrated the test's cost...

2012-12-09 20:20:19

University of Pennsylvania Researchers Report on Results of Trial in 12 Patients, Including Two Children ATLANTA, Dec. 9, 2012 /PRNewswire-USNewswire/ -- Nine of twelve leukemia patients who received infusions of their own T cells after the cells had been genetically engineered to attack the patients' tumors responded to the therapy, which was pioneered by scientists in the Perelman School of Medicine at the University of Pennsylvania. Penn Medicine researchers will present the latest...

Acting On The Immune System To Improve Chemotherapy Effectiveness
2012-12-05 13:31:15

Inserm An Inserm team in Dijon directed by François Ghiringhelli (Inserm unit 866 ℠Lipids, nutrition and cancer´) is to publish an article this week in the Nature Medicine review. The article suggests that two chemotherapy drugs frequently used to treat digestive and breast cancers may encourage the development of tumors by modulating the anti-tumoral immune response. These results reveal how the immune system can then limit the effectiveness of some cancer...

2012-12-05 08:25:42

BANNOCKBURN, Ill., Dec. 5, 2012 /PRNewswire/ -- Pinnacle Biologics, Inc., a bio-pharmaceutical technology company developing and manufacturing novel therapies for oncology and rare diseases announced today the acquisition of laser technologies for use in photodynamic therapy (PDT). The acquisition includes the Diomed(TM) PDT 630 laser and the OPTIGUIDE(TM) fiber optic diffusers, which are currently the only FDA-approved devices for use in PDT with PHOTOFRIN ® (porfimer sodium) for...

2012-12-04 08:28:02

SAN DIEGO, Dec. 04, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced it will be presenting at the DNA Vaccines 2012 Conference at the Loews Coronado Bay Resort in San Diego, California. OncoSec is a Silver Sponsor of the conference. (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO) The Company will conduct two presentations...

Mistletoe May Provide The Kiss Of Death For Cancer
2012-11-30 15:09:42

University of Adelaide Mistletoe has become an important symbol of Christmas but it also has the potential to play a vital role as an alternative therapy for sufferers of colon cancer. At the University of Adelaide in Australia, scientists are interested in how the extract of mistletoe could either assist chemotherapy or act as an alternative to chemotherapy as a treatment for colon cancer. Colon cancer is the second greatest cause of cancer death in the Western world. Mistletoe...

2012-11-29 08:29:49

The Ivy Center for Advanced Brain Tumor Treatment at Swedish discovers that an FDA-approved treatment for alcoholism may also work for brain cancer New funds from the Ivy Foundation will further this research SEATTLE, Nov. 29, 2012 /PRNewswire-USNewswire/ -- Swedish Medical Center announced today that the Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment (Ivy Center) will receive an additional $2.5 million grant from the Ben & Catherine Ivy Foundation (Ivy...

2012-11-27 15:30:30

Chemotherapy can induce changes in the brain that may affect concentration and memory, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Using positron emission tomography combined with computed tomography (PET/CT), researchers were able to detect physiological evidence of chemo brain, a common side effect in patients undergoing chemotherapy for cancer treatment. "The chemo brain phenomenon is described as 'mental fog' and 'loss...

2012-11-27 08:27:08

SAN DIEGO, Nov. 27, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that the company will provide an overview of its technologies, development programs, and outlook at the following investor conferences in upcoming weeks: New York Society of Security Analysts (NYSSA) Life Sciences Conference, NYSSA Conference Center, 1540 Broadway, New York, NY,...

2012-11-27 00:23:50

CHICAGO, Nov. 27, 2012 /PRNewswire-USNewswire/ -- Chemotherapy can induce changes in the brain that may affect concentration and memory, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). Using positron emission tomography combined with computed tomography (PET/CT), researchers were able to detect physiological evidence of chemo brain, a common side effect in patients undergoing chemotherapy for cancer treatment. "The...